全文预览已结束
下载本文档
版权说明:本文档由用户提供并上传,收益归属内容提供方,若内容存在侵权,请进行举报或认领
文档简介
Wnt inhibitorsICG-001M.Wt:548.63Formula:C33H32N4O4Solubility:DMSO 110mg/mL Water 99%Storage:at -20 2 yearsCAS No.:780757-88-2Biological ActivityICG-001 is a selective Wnt/-catenin signalling inhibitor with an IC50 of 3M. After selectively binding of ICG-001 to the NH2 terminus of cyclic AMP response element binding protein (CREB), ICG-001 prevented beta-catenin/TCF signaling. ICG-001 elevated the activities of caspase in colon carcinoma cell lines, but not normal cells via down regulation of survivin. It is exhibited that ICG-001 rescues defects in neuronal differentiation and reverse pulmonary fibrosis. ICG-001 also suppressed the interaction between CREB and -catenin. 1ICG-001 selectively induces apoptosis in transformed cells but not in normal colon cells. And ICG-001 reduces in vitro growth of colon carcinoma cells. ICG-001 efficaciously treated the colon cancer in the Min mouse and nude mouse xenograft models. XAV 939M.Wt:312.31Formula:C14H11F3N2OSSolubility:DMSO 3mg/mL Water 99%Storage:at -20 2 yearsCAS No.:284028-89-3Biological ActivityXAV 939 is a small molecule and selective Wnt pathway transcription factor -catenin-mediated transcription inhibitor and axin stabilizing agent with IC50 of 11 and 4nM for the inhibition of TNKS1 and TNKS2, respectively. It stimulates beta-catenin degradation by stabilizing axin, the concentration-limiting component of the destruction complex and stabilizes axin by inhibiting the poly-ADP-ribosylating enzymes tankyrase 1 and tankyrase 2. Both tankyrase isoforms interact with a highly conserved domain of axin and stimulate its degradation through the ubiquitin-proteasome pathway. Deregulated Wnt/b-catenin pathway activity has been implicated in many cancers. Hedgehog inhibitorsCyclopamineM.Wt:411.62Formula:C27H41NO2Solubility:DMSO 6mg/mL Water 99%Storage:at -20 2 yearsCAS No.:4449-51-8Biological ActivityCyclopamine inhibits the hedgehog signaling pathway (Hh) by influencing the balance between the active and inactive forms of the Smoothened protein. The hedgehog signaling pathway carries out important functions in embryonic development and when it goes awry, deformities can occur. However, errant activation of the pathway can also trigger cancer in adult humans. 1Cyclopamine is a lipophilic compound extracted from the lily Veratrum californicum. It antagonizes Smo activity by binding to its heptahelical bundle. Thus, it can block pathway activation resulting in any of the two upstream events of Smoi.e., either from PTCH mutations or from Hh ligand over-expression. Cyclopamine is currently being investigated as a treatment agent in basal cell carcinoma, medulloblastoma, and rhabdomyosarcoma, tumors connected to excessive Hh activity,etc. 2In preclinical models of rodent and human prostate cancer, cyclopamine can inhibit tumor growth as well as tumor progression. Administration of cyclopamine causes both down-regulation of proliferation and initiation of apoptosis, with consequent reduction in tumor size. Administration of cyclopamine in a lethal, metastatic rodent model of prostate cancer completely abrogates systemic metastases and dramatically improves survivalGDC-0449 (Vismodegib)M.Wt:421.3Formula:C19H14Cl2N2O3SSolubility:DMSO 84mg/mL Water 99%Storage:at -20 2 yearsCAS No.:879085-55-9Biological ActivityGDC-0449 (Vismodegib) is a more potent novel and specific synthetic oral hedgehog pathway inhibitor with an IC50 of 3 nM. It targets the Hedgehog signaling pathway, blocking the activities of the Hedgehog-ligand cell surface receptors PTCH and/or SMO and suppressing Hedgehog signaling. The Hedgehog signaling pathway plays an important role in tissue growth and repair; aberrant constitutive activation of Hedgehog pathway signaling and uncontrolled cellular proliferation may be associated with mutations in the Hedgehog-ligand cell surface receptors PTCH and SMO. It inhibits the growth of primary pancreatic xenografts without non-specifically inhibiting pancreatic cell proliferation in vitro and has recently entered the clinic. It also inhibits ABCG2, Pgp, and MRP1-important ABC transporters associated with MDR. The IC50 values of GDC-0449 (Vismodegib) for inhibition of ABCG2 and Pgp were about1.4 and 3.0 M, respectively. It has been used to treat medulloblastoma in animal modelsLY2940680M.Wt:512.5Formula:C26H24F4N6OSolubility:DMSO 1mg/mL Water 99%Storage:at -20 2 yearsCAS No.:N/ABiological ActivityLY2940680 is a potent agent used to treat cancer. A study will explore the changes in a cancer marker level in skin, hair follicles and tumor cells. Finally, the study will help document any antitumor activity this drug may haveSMO inhibitorsLDE225 (NVP-LDE225)M.Wt:485.5Formula:C26H26F3N3O3Solubility:DMSO 97mg/mL Water 99%Storage:at -20 2 yearsCAS No.:956697-53-3Biological ActivityLDE225 (NVP-LDE225) is a novel and specific, orally bioavailable Smo inhibitor with an IC50 of 11 nM. It has been shown to potentially inhibit Hh-and Smo-dependent proliferation in vivo. It also induced the regression of preformed basaloid lesions with an IC50 of 150nmol/l and almost complete regression at 1.5mol/l. Topical application of a 1
温馨提示
- 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
- 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
- 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
- 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
- 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
- 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
- 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。
最新文档
- 2026年网络安全口碑提升与舆情应对报告
- 2026年汽车行业电动化转型与产业链升级报告
- 2026年环保行业采购招标与供应商评估报告
- 2026年电子商务平台用户行为分析报告及市场前景展望
- 2026年新能源汽车零部件行业报告:市场前景与竞争格局
- 2026年化妆品行业店长领导力培养与员工绩效考核报告
- 2026年农产品冷链物流信息化报告:生鲜、果蔬、肉禽、水产供应链损耗控制与信息化建设
- 2026年汽车行业能源消耗分析与智能化管理报告
- 2026年白领阶层午餐消费习惯与偏好调查报告
- 2026年医药行业用户直连工厂模式创新报告
- 乡村振兴基础设施工程监理规划
- 2026年新疆农牧业投资集团招聘面试题及答案
- 卫生院疟疾培训课件
- 江苏省2025年普通高中学业水平合格性考试语文试卷 含答案
- 胃肠解剖课件
- 污水站有限空间安全培训课件
- 直播助农培训课件
- 江苏信息合格考试真题及答案
- 数字化染整技术专业教学标准(高等职业教育专科)2025修订
- JG/T 347-2012聚碳酸酯(PC)实心板
- 《病原体的多样性与识别》课件
评论
0/150
提交评论